What is the recommended dosing of oral tranexamic acid 650 mg tablets for controlling persistent gingival bleeding after a tooth extraction?

Oral Tranexamic Acid 650 mg Tablets for Post-Extraction Gingival Bleeding

For persistent gingival bleeding after tooth extraction, oral tranexamic acid 650 mg tablets are not the recommended formulation—use a 5% mouthwash solution (10 mL) applied topically 3-4 times daily for 1-2 days instead, as systemic oral tablets do not achieve therapeutic salivary concentrations. 1, 2

Why Oral Tablets Are Ineffective for Gingival Bleeding

• Oral tablets fail to deliver tranexamic acid to saliva at therapeutic levels. After 1 g oral administration, plasma concentrations reach approximately 7 micrograms/mL at 120 minutes, but no detectable tranexamic acid appears in saliva. 2

• Topical mouthwash achieves salivary concentrations exceeding 200 micrograms/mL within 30 minutes and maintains therapeutic levels for over 2 hours, which is necessary to inhibit fibrinolysis in the oral cavity. 2

• Fibrinolysis in the oral cavity can only be inhibited by local administration, not systemic absorption from oral tablets. 2

Correct Dosing Protocol for Post-Extraction Bleeding

Standard Approach (Not on Anticoagulants)

• Use 5-10 mL of 5% tranexamic acid mouthwash (not 650 mg tablets):

  • Apply 5-10 minutes before the dental procedure 1
  • Continue 3-4 times daily for 1-2 days after extraction 1, 3
  • Instruct patients to apply local pressure to control minor oozing 1

• Alternative topical method: Soak gauze in tranexamic acid solution and apply as a pressure pack directly to the extraction site. 3, 4

For Patients on Vitamin K Antagonists (Warfarin)

• Continue warfarin therapy without interruption 1, 3
• Co-administer tranexamic acid mouthwash using the same topical protocol above 1, 3
• This approach maintains INR at therapeutic levels while keeping bleeding risk below 5% 1
• Minor gingival oozing may still occur but is self-limiting with continued mouthwash use and local pressure 1

For Patients on NOACs (Direct Oral Anticoagulants)

• Tranexamic acid mouthwash does not reduce periprocedural or early postoperative bleeding in patients on NOACs (apixaban, rivaroxaban, dabigatran, edoxaban). 5
• It may reduce delayed bleeding (occurring after 24 hours) and bleeding after multiple extractions. 5
• Continue the NOAC and use standard local hemostatic measures (sutures, gauze pressure, gelatin foam). 5

When IV Tranexamic Acid Is Indicated (Not Oral Tablets)

The FDA-approved indication for intravenous tranexamic acid in dental extraction is limited to patients with hemophilia: 6

• 10 mg/kg IV as a single dose immediately before extraction 6
• Post-extraction: 10 mg/kg IV 3-4 times daily for 2-8 days 6
• Infuse no faster than 1 mL/minute to avoid hypotension 6

Renal Dose Adjustments for IV Formulation

Serum Creatinine (mg/dL)	IV Dosing
1.36–2.83	10 mg/kg twice daily [6]
2.83–5.66	10 mg/kg once daily [6]
>5.66	10 mg/kg every 48 hours [6]

Critical Contraindications

• Subarachnoid hemorrhage: Tranexamic acid may cause cerebral edema and infarction. 6
• Active intravascular clotting: Increases thromboembolic risk. 6
• Gastrointestinal bleeding: Extended-use high-dose IV tranexamic acid increases venous thromboembolism (RR 2.01) and seizures (RR 1.73) without reducing mortality. 7, 8

Common Pitfalls to Avoid

• Do not prescribe 650 mg oral tablets for gingival bleeding—they will not work because tranexamic acid does not reach saliva after systemic absorption. 2

• Do not use IV tranexamic acid for routine dental extractions in patients without hemophilia—topical mouthwash is sufficient and avoids systemic thrombotic risk. 1, 3

• Do not interrupt warfarin for simple extractions—continuing warfarin with topical tranexamic acid is safer than bridging with heparin, which increases bleeding risk. 1, 3

• Do not administer tranexamic acid to patients with recent stroke or intracranial hemorrhage unless warfarin has been fully reversed with prothrombin complex concentrate and vitamin K. 9

Practical Implementation Algorithm

1. Assess anticoagulation status:

   • Not anticoagulated → topical mouthwash alone 1
   • On warfarin → continue warfarin + topical mouthwash 1, 3
   • On NOAC → continue NOAC + local measures (mouthwash has limited benefit) 5
   • Hemophilia → IV tranexamic acid per FDA protocol 6

2. Apply topical tranexamic acid:

   • 5-10 mL of 5% solution before extraction 1
   • Repeat 3-4 times daily for 1-2 days 1

3. Manage persistent bleeding:

   • Pressure pack soaked in tranexamic acid 4
   • Gelatin foam or additional sutures 4
   • If bleeding continues beyond 48 hours, reassess for coagulopathy or surgical complications 1